[1]
2022. Hepatic Adverse Effects of Anti-Mycobacterium Tuberculosis Drugs and Their Associations with Various Genetic Variants. Precision Medicine Communications. 2, 1 (Jun. 2022), 59–78. DOI:https://doi.org/10.55627/pmc.002.001.0053.